Jan Willem Vrijbloed
Chief Tech/Sci/R&D Officer at Neurotune AG
Profile
Jan Willem Vrijbloed is currently working as the Director-Preclinical & Clinical Development at Neurotune AG.
Previously, he worked as a Principal at the University of Zurich and as the Head-Development at Spexis Ltd.
He holds a doctorate degree from the University of Groningen.
Jan Willem Vrijbloed active positions
| Companies | Position | Start |
|---|---|---|
Neurotune AG
 Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Chief Tech/Sci/R&D Officer | 03/11/2009 |
Former positions of Jan Willem Vrijbloed
| Companies | Position | End |
|---|---|---|
| SPEXIS AG | Corporate Officer/Principal | - |
| University of Zurich | Corporate Officer/Principal | - |
Training of Jan Willem Vrijbloed
| University of Groningen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SPEXIS AG | Health Technology |
| Private companies | 1 |
|---|---|
Neurotune AG
Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Jan Willem Vrijbloed
